NewsRx.com - June 20, 2002
Saturday, June 22, 2002
New Module Helps Physicians Monitor, Treat Adhd Patients NewsRx.com - June 20, 2002
Physicians treating attention deficit hyperactivity disorder (ADHD) are now using a pioneering new resource called the ADHD Impact Module (AIM) to measure the impacts of ADHD on patient and family quality of life.
An article on the development and evaluation processes of the AIM was published in the Archives of Pediatrics & Adolescent Medicine, a member of the JAMA family of journals. Developed over the past four years by HealthAct, Inc., the AIM is a brief survey that provides physicians with a system for the continuous monitoring of ADHD patient care and treatment.
As discussed in the paper, ADHD impacts lives in a multitude of ways beyond the primary symptoms of hyperactivity, impulsiveness, and/or inattentiveness. Relief from these symptoms does not always translate to an improvement in broader issues from living with the ADHD, such as quality of life at home, school, or with peers. Symptom checklists support diagnosis decision-making but do not evaluate the impacts of ADHD and treatment plans on the everyday lives of families and children.
The AIM is a new resource for measuring ADHD outcomes and complements the American Academy of Pediatrics (AAP) guidelines for the treatment of ADHD released in the Fall of 2001. Recognizing ADHD as a chronic condition, longitudinal reporting from the AIM monitors patient outcomes over time. Diagnostic information, treatment profiles, and management strategies are included in patient-specific reports to provide insight into the patient and family's responses to care.
Targeted outcomes areas of the AIM include an in-depth assessment of the quality of life for the patient and family, attitudes towards the condition and treatment, adherence to treatment plans, and other relevant issues in the overall management of ADHD. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports.
To see more of the NewsRx.com, or to subscribe, go to http://www.newsrx.com . ©Copyright 2002, Pain & Central Nervous System Week via NewsRx.com & NewsRx.net